Rush-Presbyterian St. Lukes Medical Center is a clinical research site located in Chicago, Illinois, United States.
Crixeo Clinical Trials Trust Score: 19/100 (FAILING). This profile has not yet been claimed by the site owner.
Rush-Presbyterian St. Lukes Medical Center has participated in 10 clinical trials.
Therapeutic areas: Hypertension, Diabetic Nephropathies, Osteoarthritis.
Sponsors: Boehringer Ingelheim, Novartis Pharmaceuticals, Baxalta now part of Shire.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Illinois · View every site in Chicago
Trust Score: 19/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Rush-Presbyterian St. Lukes Medical Center has a Crixeo Trust Score of 19/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Rush-Presbyterian St. Lukes Medical Center has 10 clinical trials on record. Their work covers Hypertension, Diabetic Nephropathies, Osteoarthritis.
Rush-Presbyterian St. Lukes Medical Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.